MaxCyte is a leading provider of cell engineering technology, specializing in the development and commercialization of innovative solutions for the biotechnology and pharmaceutical industries. With a focus on enhancing cell-based therapies and research, MaxCyte empowers scientists and researchers by providing advanced tools for cell transfection and gene editing. The company is committed to driving growth and expanding its market presence through strategic business development and strong customer relationships, while maintaining a dedication to compliance and environmental safety. MaxCyte values diversity and is an Equal Opportunity Employer, ensuring a fair and inclusive workplace for all.